Madrigal Pharmaceuticals, Inc.
IT ˙ BIT ˙ US5588681057
412,50 € 0,00 (0,00%)
2026-06-04
CENA AKCJI
SecurityIT:1MDGL / Madrigal Pharmaceuticals, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership191,294 shares
Latest Disclosed Value $ 100,137,080
Morgan Stanley reports 27.14% increase in ownership of 1MDGL / Madrigal Pharmaceuticals, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 191,294 shares of Madrigal Pharmaceuticals, Inc. (IT:1MDGL) valued at $84,972,795 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 150,462 shares of Madrigal Pharmaceuticals, Inc.. This represents a change in shares of 27.14% during the quarter. The current value of the position is $78,908,775 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 191,294 40,832 27.14 100,137 14.29 0.0060
2026-05-27 2025-12-31 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 150,462 -99,185 -39.73 87,620 -23.48 0.0052
2026-02-13 2025-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 150,462 -99,185 87,620 0.0052
2026-05-27 2025-09-30 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 249,647 1,685 0.68 114,503 52.58 0.0069
2025-11-14 2025-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 249,647 1,685 114,503 0.0069
2025-08-15 2025-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 247,962 -136,866 -35.57 75,043 -41.13 0.0049
2025-05-15 2025-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 384,828 166,347 76.14 127,467 89.07 0.0091
2025-05-15 2024-12-31 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 218,481 -50,913 -18.90 67,417 17.92 0.0047
2025-02-14 2024-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 218,481 -50,913 67,417 0.0047
2025-05-14 2024-09-30 13F/A-2 MADRIGAL PHARMACEUTICALS COM 558868105 269,394 49,363 22.43 57,171 -7.26 0.0041
2025-02-14 2024-09-30 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 269,394 49,363 57,171 0.0041
2024-11-14 2024-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 269,394 49,363 57,171 0.0041
2025-05-14 2024-06-30 13F/A-2 MADRIGAL PHARMACEUTICALS COM 558868105 220,031 -68,575 -23.76 61,644 -20.01 0.0048
2024-10-17 2024-06-30 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 220,031 -68,575 61,644 0.0048
2024-08-14 2024-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 220,031 -68,575 61,644 0.0048
2024-10-17 2024-03-31 13F/A-2 MADRIGAL PHARMACEUTICALS COM 558868105 288,606 136,688 89.97 77,069 119.26 0.0062
2024-08-16 2024-03-31 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 288,606 136,688 77,069 0.0007
2024-05-15 2024-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 288,606 136,688 77,069 0.0062
2024-08-16 2023-12-31 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 151,918 -19,855 -11.56 35,151 40.12 0.0031
2024-02-13 2023-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 151,918 -19,855 35,151 0.0031
2023-11-15 2023-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 171,773 97,480 131.21 25,086 46.17 0.0026
2023-08-14 2023-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 74,293 -73,486 -49.73 17,162 -52.06 0.0017
2023-05-15 2023-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 147,779 38,359 35.06 35,801 12.72 0.0038
2023-02-14 2022-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 109,420 50,356 85.26 31,759 727.49 0.0036
2022-11-14 2022-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 59,064 -23,889 -28.80 3,838 -35.38 0.0005
2022-10-27 2022-06-30 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 82,953 -15,071 -15.37 5,939 -38.24 0.0008
2022-08-15 2022-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 82,953 -15,071 5,939 0.0008
2022-10-27 2022-03-31 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 98,024 49,686 102.79 9,617 134.73 0.0013
2022-05-13 2022-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 98,024 49,686 9,617 0.0013
2022-02-14 2021-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 48,338 -19,830 -29.09 4,097 -24.66 0.0005
2021-11-15 2021-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 68,168 -25,509 -27.23 5,438 -40.41 0.0007
2021-08-23 2021-06-30 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 93,677 -169,221 -64.37 9,126 -70.32 0.0012
2021-08-16 2021-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 93,677 -169,221 9,126 0.0003
2021-05-17 2021-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 262,898 211,311 409.62 30,751 436.29 0.0045
2021-02-16 2020-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 51,587 23,527 83.85 5,734 72.09 0.0009
2020-11-13 2020-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 28,060 1,406 5.28 3,332 10.40 0.0006
2020-08-14 2020-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 26,654 1,880 7.59 3,018 82.58 0.0007
2020-05-26 2020-03-31 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 24,774 1,110 4.69 1,653 -23.33 0.0004
2020-05-15 2020-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 24,774 1,110 1,653 126.9849
2020-02-14 2019-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 23,664 -11,319 -32.36 2,156 -28.54 0.0005
2019-11-14 2019-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 34,983 20,479 141.20 3,017 98.36 0.0008
2019-08-14 2019-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 14,504 1,064 7.92 1,521 -9.68 0.0004
2019-05-15 2019-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 13,440 -50,539 -78.99 1,684 -76.65 0.0005
2019-02-14 2018-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 63,979 42,296 195.07 7,212 55.33 0.0022
2019-04-23 2018-09-30 13F/A-2 MADRIGAL PHARMACEUTICALS COM 558868105 21,683 -2,089 -8.79 4,643 -30.17 0.0012
2018-11-20 2018-09-30 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 21,683 0 4,643 0.0012
2018-11-14 2018-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 21,683 -2,089 4,643
2019-04-23 2018-06-30 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 23,772 11,472 93.27 6,649 363.02 0.0018
2018-08-14 2018-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 23,772 11,472 6,649
2019-04-23 2018-03-31 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 12,300 2,183 21.58 1,436 54.74 0.0004
2018-05-14 2018-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 12,300 2,183 1,436
2019-04-23 2017-12-31 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 10,117 4,471 79.19 928 263.92 0.0003
2018-02-14 2017-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 10,117 4,471 928
2017-11-14 2017-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 5,646 1,718 43.74 255 304.76 0.0001
2017-08-11 2017-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 3,928 1,756 80.85 63 90.91 0.0000
2017-05-22 2017-03-31 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 2,172 1,840 554.22 33 560.00 0.0000
2017-05-12 2017-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 2,172 33
2017-02-22 2016-12-31 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 332 82 32.80 5 66.67 0.0000
2017-02-13 2016-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 332 5
2016-11-10 2016-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 250 250 3 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.